Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 45, 2011, Pages 18277-18282

  Johnson, Lincoln V ^a   Forest, David L ^a   Banna, Christopher D ^a   Radeke, Carolyn M ^a   Maloney, Michelle A ^a   Hu, Jane ^b   Spencer, Christine N ^a   Walker, Aimee M ^a   Tsie, Marlene S ^a   Bok, Dean ^b   Radeke, Monte J ^a   Anderson, Don H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID P COMPONENT; APOLIPOPROTEIN E; CLUSTERIN; COMPLEMENT MEMBRANE ATTACK COMPLEX; VITRONECTIN;

ARTICLE; CELL CULTURE; CELL GROWTH; CELL ULTRASTRUCTURE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUSEN; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; PATHOGENESIS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; RETINA MACULA AGE RELATED DEGENERATION;

APOLIPOPROTEINS E; CELL CULTURE TECHNIQUES; COMPLEMENT ACTIVATION; HUMANS; IMMUNOHISTOCHEMISTRY; MACULAR DEGENERATION; MODELS, BIOLOGICAL; RETINAL DRUSEN; RETINAL PIGMENT EPITHELIUM;

EID: 81055130123     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1109703108     Document Type: Article

References (52)

1. Farkas TG, Sylvester V, Archer D (1971) The ultrastructure of drusen. Am J Ophthalmol 71:1196-1205.
2. Sarks SH (1976) Ageing and degeneration in the macular region: A clinico-pathological study. Br J Ophthalmol 60:324-341.
3. Green WR, Key SN, 3rd (2005) Senile macular degeneration: A histopathologic study. 1977. Retina 25(5, Suppl):180-250, discussion 250-254.
4. Burns RP, Feeney-Burns L (1980) Clinico-morphologic correlations of drusen of Bruch's membrane. Trans Am Ophthalmol Soc 78:206-225. (Pubitemid 11035013)
5. Ishibashi T, Patterson R, Ohnishi Y, Inomata H, Ryan SJ (1986) Formation of drusen in the human eye. Am J Ophthalmol 101:342-353. (Pubitemid 16132662)
6. Kliffen M, van der Schaft TL, Mooy CM, de Jong PT (1997) Morphologic changes in age-related maculopathy. Microsc Res Tech 36:106-122. (Pubitemid 27130777)
7. Hageman GS, Mullins RF (1999) Molecular composition of drusen as related to substructural phenotype. Mol Vis 5:28.
8. Mullins RF, Aptsiauri N, Hageman GS (2001) Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye (Lond) 15:390-395. (Pubitemid 32600863)
9. Sarks SH, Arnold JJ, Killingsworth MC, Sarks JP (1999) Early drusen formation in the normal and aging eye and their relation to age related maculopathy: A clinicopathological study. Br J Ophthalmol 83:358-368. (Pubitemid 29112419)
10. Sarks S, Cherepanoff S, Killingsworth M, Sarks J (2007) Relationship of Basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration. Invest Ophthalmol Vis Sci 48:968-977. (Pubitemid 351261384)
11. Russell SR, Mullins RF, Schneider BL, Hageman GS (2000) Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration. Am J Ophthalmol 129:205-214. (Pubitemid 30089281)
12. Anderson DH, Mullins RF, Hageman GS, Johnson LV (2002) A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134:411-431.
13. Anderson DH, et al. (2004) Characterization of beta amyloid assemblies in drusen: The deposits associated with aging and age-related macular degeneration. Exp Eye Res 78:243-256. (Pubitemid 38077231)
14. Hageman GS, et al. (2001) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20:705-732. (Pubitemid 32918285)
15. Anderson DH, et al. (2010) The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visited. Prog Retin Eye Res 29: 95-112.
16. Ishida BY, et al. (2004) Regulated expression of apolipoprotein E by human retinal pigment epithelial cells. J Lipid Res 45:263-271. (Pubitemid 38228823)
17. An E, et al. (2006) Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donors. J Proteome Res 5:2599-2610. (Pubitemid 44595162)
18. Suuronen T, Nuutinen T, Ryhänen T, Kaarniranta K, Salminen A (2007) Epigenetic regulation of clusterin/apolipoprotein J expression in retinal pigment epithelial cells. Biochem Biophys Res Commun 357:397-401. (Pubitemid 46603144)
19. Kim YH, et al. (2009) Regulated secretion of complement factor H by RPE and its role in RPE migration. Graefes Arch Clin Exp Ophthalmol 247:651-659.
20. Gehrs KM, Jackson JR, Brown EN, Allikmets R, Hageman GS (2010) Complement, age-related macular degeneration and a vision of the future. Arch Ophthalmol 128: 349-358.
21. Hecker LA, Edwards AO (2010) Genetic control of complement activation in humans and age related macular degeneration. Adv Exp Med Biol 703:49-62.
22. Johnson LV, Ozaki S, Staples MK, Erickson PA, Anderson DH (2000) A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res 70:441-449. (Pubitemid 30662042)
23. Johnson LV, Leitner WP, Staples MK, Anderson DH (2001) Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Exp Eye Res 73:887-896. (Pubitemid 34112114)
24. Anderson DH, et al. (2001) Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: Implications for the process of drusen formation. Am J Ophthalmol 131:767-781. (Pubitemid 32522648)
25. Crabb JW, et al. (2002) Drusen proteome analysis: An approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA 99:14682-14687. (Pubitemid 35334544)
26. Wang L, et al. (2010) Abundant lipid and protein components of drusen. PLoS One 5: e10329.
27. Wasmuth S, Lueck K, Baehler H, Lommatzsch A, Pauleikhoff D (2009) Increased vitronectin production by complement-stimulated human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 50:5304-5309.
28. Mullins RF, Russell SR, Anderson DH, Hageman GS (2000) Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 14:835-846. (Pubitemid 30241660)
29. Alcazar O, et al. (2009) Proteomics characterization of cell membrane blebs in human retinal pigment epithelium cells. Mol Cell Proteomics 8:2201-2211.
30. Tylman M, Bengtson JP, Bengtsson A (2003) Activation of the complement system by different autologous transfusion devices: An in vitro study. Transfusion 43:395-399. (Pubitemid 36351133)
31. Yang P, Tyrrell J, Han I, Jaffe GJ (2009) Expression and modulation of RPE cell membrane complement regulatory proteins. Invest Ophthalmol Vis Sci 50:3473-3481.
32. Vogt SD, Barnum SR, Curcio CA, Read RW (2006) Distribution of complement anaphylatoxin receptors and membrane-bound regulators in normal human retina. Exp Eye Res 83:834-840. (Pubitemid 44292679)
33. Killingsworth MC (1987) Age-related components of Bruch's membrane in the human eye. Graefes Arch Clin Exp Ophthalmol 225:406-412.
34. Ulshafer RJ, Allen CB, Nicolaissen B, Jr., Rubin ML (1987) Scanning electron microscopy of human drusen. Invest Ophthalmol Vis Sci 28:683-689. (Pubitemid 17054189)
35. Curcio CA, Millican CL, Bailey T, Kruth HS (2001) Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci 42:265-274. (Pubitemid 32059440)
36. Curcio CA, Johnson M, Huang JD, Rudolf M (2010) Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration. J Lipid Res 51: 451-467.
37. Malek G, Li CM, Guidry C, Medeiros NE, Curcio CA (2003) Apolipoprotein B in cholesterol- containing drusen and basal deposits of human eyes with age-related maculopathy. Am J Pathol 162:413-425. (Pubitemid 36267849)
38. Li C-M, et al. (2005) Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: Initial characterization. Invest Ophthalmol Vis Sci 46:2576-2586. (Pubitemid 43119509)
39. Meri S, Pangburn MK (1990) A mechanism of activation of the alternative complement pathway by the classical pathway: Protection of C3b from inactivation by covalent attachment to C4b. Eur J Immunol 20:2555-2561.
40. Holers VM (2008) The spectrum of complement alternative pathway-mediated diseases. Immunol Rev 223:300-316.
41. Gaboriaud C, et al. (2004) Structure and activation of the C1 complex of complement: Unraveling the puzzle. Trends Immunol 25:368-373. (Pubitemid 38780953)
42. Bohlson SS, Fraser DA, Tenner AJ (2007) Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions. Mol Immunol 44:33-43. (Pubitemid 44647109)
43. Navratil JS, Watkins SC, Wisnieski JJ, Ahearn JM (2001) The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells. J Immunol 166:3231-3239. (Pubitemid 33117322)
44. Nauta AJ, et al. (2002) Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur J Immunol 32:1726-1736. (Pubitemid 34679160)
45. Païdassi H, et al. (2008) C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition. J Immunol 180:2329-2338.
46. Amin S, et al. (2004) Modulation of Sub-RPE deposits in vitro: A potential model for age-related macular degeneration. Invest Ophthalmol Vis Sci 45:1281-1288. (Pubitemid 38859300)
47. Marin-Castaño ME, et al. (2006) Repetitive nonlethal oxidant injury to retinal pigment epithelium decreased extracellular matrix turnover in vitro and induced sub-RPE deposits in vivo. Invest Ophthalmol Vis Sci 47:4098-4112. (Pubitemid 46044329)
48. Hollyfield JG, Perez VL, Salomon RG (2010) A hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration. Mol Neurobiol 41:290-298.
49. Sparrow JR (2010) Bisretinoids of RPE lipofuscin: trigger for complement activation in age-related macular degeneration. Adv Exp Med Biol 703:63-74.
50. Hu J, Bok D (2001) A cell culture medium that supports the differentiation of human retinal pigment epithelium into functionally polarized monolayers. Mol Vis 7:14-19. (Pubitemid 36153646)
51. Maminishkis A, et al. (2006) Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest Ophthalmol Vis Sci 47:3612-3624. (Pubitemid 351639731)
52. Anderson DH, et al. (1999) Vitronectin gene expression in the adult human retina. Invest Ophthalmol Vis Sci 40:3305-3315.